Year To Quarter End Consolidated Statement Of Comprehensive Income

TAKARA BIO INC. - Filing #7322771

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
2,899,000,000 JPY
1,510,000,000 JPY
2,899,000,000 JPY
2,899,000,000 JPY
14,313,000,000 JPY
14,313,000,000 JPY
14,313,000,000 JPY
16,047,000,000 JPY
Other comprehensive income
Foreign currency translation adjustment
2,882,000,000 JPY
4,478,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-5,000,000 JPY
-163,000,000 JPY
Other comprehensive income
2,877,000,000 JPY
4,315,000,000 JPY
Comprehensive income
4,387,000,000 JPY
20,363,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
4,343,000,000 JPY
20,319,000,000 JPY
Comprehensive income attributable to non-controlling interests
44,000,000 JPY
43,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.